Toujeo
ApprovedCompleted 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Diabetes Mellitus, Type 2
Conditions
Diabetes Mellitus, Type 2
Trial Timeline
Jul 10, 2023 → Jan 21, 2025
NCT ID
NCT05780151About Toujeo
Toujeo is a approved stage product being developed by MIRA Pharmaceuticals for Diabetes Mellitus, Type 2. The current trial status is completed. This product is registered under clinical trial identifier NCT05780151. Target conditions include Diabetes Mellitus, Type 2.
Hype Score Breakdown
Clinical
30
Activity
20
Company
2
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT05780151 | Approved | Completed |
Competing Products
20 competing products in Diabetes Mellitus, Type 2